ABSI
Price
$4.53
Change
-$0.34 (-6.98%)
Updated
Oct 17, 04:59 PM (EDT)
Capitalization
677.34M
19 days until earnings call
Intraday Buy/Sell Signals
NTLA
Price
$24.75
Change
-$0.16 (-0.64%)
Updated
Oct 17 closing price
Capitalization
2.66B
19 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

ABSI vs NTLA

Header iconABSI vs NTLA Comparison
Open Charts ABSI vs NTLABanner chart's image
Absci
Price$4.53
Change-$0.34 (-6.98%)
Volume$53.64K
Capitalization677.34M
Intellia Therapeutics
Price$24.75
Change-$0.16 (-0.64%)
Volume$3.84M
Capitalization2.66B
ABSI vs NTLA Comparison Chart in %
ABSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NTLA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABSI vs. NTLA commentary
Oct 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABSI is a Hold and NTLA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 18, 2025
Stock price -- (ABSI: $4.87 vs. NTLA: $24.91)
Brand notoriety: ABSI and NTLA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABSI: 173% vs. NTLA: 82%
Market capitalization -- ABSI: $677.34M vs. NTLA: $2.66B
ABSI [@Biotechnology] is valued at $677.34M. NTLA’s [@Biotechnology] market capitalization is $2.66B. The market cap for tickers in the [@Biotechnology] industry ranges from $106.87B to $0. The average market capitalization across the [@Biotechnology] industry is $2.06B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABSI’s FA Score shows that 0 FA rating(s) are green whileNTLA’s FA Score has 0 green FA rating(s).

  • ABSI’s FA Score: 0 green, 5 red.
  • NTLA’s FA Score: 0 green, 5 red.
According to our system of comparison, both ABSI and NTLA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABSI’s TA Score shows that 5 TA indicator(s) are bullish while NTLA’s TA Score has 5 bullish TA indicator(s).

  • ABSI’s TA Score: 5 bullish, 4 bearish.
  • NTLA’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, both ABSI and NTLA are a good buy in the short-term.

Price Growth

ABSI (@Biotechnology) experienced а +21.45% price change this week, while NTLA (@Biotechnology) price change was -2.16% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.56%. For the same industry, the average monthly price growth was +16.03%, and the average quarterly price growth was +79.42%.

Reported Earning Dates

ABSI is expected to report earnings on Nov 05, 2025.

NTLA is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+1.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NTLA($2.66B) has a higher market cap than ABSI($677M). NTLA YTD gains are higher at: 113.636 vs. ABSI (85.878). ABSI has higher annual earnings (EBITDA): -100.08M vs. NTLA (-501.87M). NTLA has more cash in the bank: 460M vs. ABSI (117M). ABSI has less debt than NTLA: ABSI (7.41M) vs NTLA (103M). NTLA has higher revenues than ABSI: NTLA (52.9M) vs ABSI (4.14M).
ABSINTLAABSI / NTLA
Capitalization677M2.66B25%
EBITDA-100.08M-501.87M20%
Gain YTD85.878113.63676%
P/E RatioN/AN/A-
Revenue4.14M52.9M8%
Total Cash117M460M25%
Total Debt7.41M103M7%
FUNDAMENTALS RATINGS
NTLA: Fundamental Ratings
NTLA
OUTLOOK RATING
1..100
14
VALUATION
overvalued / fair valued / undervalued
1..100
37
Fair valued
PROFIT vs RISK RATING
1..100
97
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABSINTLA
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
Momentum
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 3 days ago
71%
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 3 days ago
89%
Bullish Trend 3 days ago
78%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
Aroon
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
ABSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NTLA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IJMSX13.99N/A
N/A
VY® JPMorgan Mid Cap Value S
DCCAX30.13N/A
N/A
Macquarie Small Cap Core A
DRDCX25.42N/A
N/A
Dearborn Partners Rising Dividend C
RGGCX26.31N/A
N/A
Victory RS Global C
FAPMX13.84N/A
N/A
Fidelity Advisor Healthy Future I